Raymond James & Associates’s Itron ITRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-17,900
Closed -$26.9K 3962
2022
Q4
$26.9K Buy
+17,900
New +$884K ﹤0.01% 3770
2020
Q3
Sell
-17,600
Closed -$79K 3637
2020
Q2
$79K Buy
+17,600
New +$1.12M ﹤0.01% 3325
2019
Q3
Sell
-13,000
Closed -$44K 3658
2019
Q2
$44K Buy
+13,000
New +$722K ﹤0.01% 3512

Other funds holding ITRI

Raymond James & Associates's ITRI Position: Q3 2024 in Review

Raymond James & Associates increased its Itron (ITRI) stake by 70% in Q3 2024, buying an estimated $1.69M and bringing the position to 40,527 shares worth $4.33M. The position accounts for ﹤0.01% of the portfolio, ranked #1754.

Raymond James & Associates first reported a position in ITRI in Q1 2018 and has held it in 27 quarters since. The position peaked at $15.8M in Q3 2018. 424 funds tracked by Wall St. Rank hold ITRI as of Q3 2024.

  • Raymond James & Associates held 40,527 shares of Itron worth $4.33M as of Q3 2024.
  • Raymond James & Associates bought 16,663 Itron shares in Q3 2024, an estimated $1.69M.
  • Itron made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1754 holding.
  • Raymond James & Associates first reported a position in Itron in Q1 2018 and has held it in 27 quarters since.
  • Raymond James & Associates's Itron position peaked at $15.8M in Q3 2018.
  • 424 funds tracked by Wall St. Rank held Itron as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.